Beta Drugs consolidated net profit declines 4.80% in the December 2025 quarter
(15 Feb 2026)

Back
Net profit of Beta Drugs declined 4.80% to Rs 8.52 crore in the quarter ended December 2025 as against Rs 8.95 crore during the previous quarter ended December 2024. Sales declined 1.16% to Rs 87.27 crore in the quarter ended December 2025 as against Rs 88.29 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales87.2788.29 -1
OPM %19.4720.90 -
PBDT14.8617.55 -15
PBT10.4714.31 -27
NP8.528.95 -5

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew